title: Magnesium administration reduces platelet hyperaggregability in NIDDM.
authors.forename: G
authors.initials: G
authors.lastname: Paolisso
authors.forename: A
authors.initials: A
authors.lastname: Tirelli
authors.forename: L
authors.initials: L
authors.lastname: Coppola
authors.forename: G
authors.initials: G
authors.lastname: Verrazzo
authors.forename: G
authors.initials: G
authors.lastname: Pizza
authors.forename: S
authors.initials: S
authors.lastname: Sgambato
authors.forename: F
authors.initials: F
authors.lastname: D'Onofrio
mesh_terms: D001786:Blood Glucose / Q000378:metabolism; D002096:C-Peptide / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D008274:Magnesium / Q000494:pharmacology*; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects*; D012016:Reference Values
chemical_list: D001786:Blood Glucose; D002096:C-Peptide; D006442:Glycated Hemoglobin; D008274:Magnesium